<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">9371658</PMID><DateCompleted><Year>1997</Year><Month>12</Month><Day>24</Day></DateCompleted><DateRevised><Year>2020</Year><Month>07</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-538X</ISSN><JournalIssue CitedMedium="Print"><Volume>71</Volume><Issue>12</Issue><PubDate><Year>1997</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells.</ArticleTitle><Pagination><StartPage>9844</StartPage><EndPage>9848</EndPage><MedlinePgn>9844-8</MedlinePgn></Pagination><Abstract><AbstractText>The composition of the cellular receptor complex for coxsackievirus B3 (CVB3) has been an area of much contention for the last 30 years. Recently, two individual components of a putative CVB3 cellular receptor complex have been identified as (i) decay-accelerating factor (DAF) and (ii) the coxsackievirus-adenovirus receptor protein (CAR). The present study elucidates the individual roles of DAF and CAR in cell entry of CVB3 Nancy. First, we confirm that the DAF-binding phenotype of CVB3 correlates to the presence of key amino acids located in the viral capsid protein, VP2. Second, using antibody blockade, we show that complete protection of permissive cells from infection by high input multiplicities of CVB3 requires a combination of both anti-DAF and anti-CAR antibodies. Finally, it is shown that expression of the CAR protein on the surface of nonpermissive DAF-expressing RD cells renders them highly susceptible to CVB3-mediated lytic infection. Therefore, although the majority of CVB3 Nancy attaches to the cell via DAF, only virus directly interacting with the CAR protein mediates lytic infection. The role of DAF in CVB3 cell infection may be analogous to that recently described for coxsackievirus A21 (D. R. Shafren, D. J. Dorahy, R. A. Ingham, G. F. Burns, and R. D. Barry, J. Virol. 71:4736-4743, 1997), in that DAF may act as a CVB3 sequestration site, enhancing viral presentation to the functional CAR protein.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shafren</LastName><ForeName>D R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Faculty of Medicine, The University of Newcastle, Australia. dshafren@mail.newcastle.edu.au</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>D T</ForeName><Initials>DT</Initials></Author><Author ValidYN="Y"><LastName>Barry</LastName><ForeName>R D</ForeName><Initials>RD</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568771">CLMP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D062727">Coxsackie and Adenovirus Receptor-Like Membrane Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011991">Receptors, Virus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C105941">coxsackievirus B receptor</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062727" MajorTopicYN="N">Coxsackie and Adenovirus Receptor-Like Membrane Protein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011991" MajorTopicYN="N">Receptors, Virus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012208" MajorTopicYN="N">Rhabdomyosarcoma</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014407" MajorTopicYN="N">Tumor Cells, Cultured</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1997</Year><Month>11</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1997</Year><Month>11</Month><Day>26</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1997</Year><Month>11</Month><Day>26</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>1997</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">9371658</ArticleId><ArticleId IdType="pmc">PMC230302</ArticleId><ArticleId IdType="doi">10.1128/JVI.71.12.9844-9848.1997</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Virol. 1971 Oct;8(4):509-15</Citation><ArticleIdList><ArticleId IdType="pubmed">4331654</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1997 Jun;71(6):4736-43</Citation><ArticleIdList><ArticleId IdType="pubmed">9151867</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1976 Feb 26;259(5545):679-81</Citation><ArticleIdList><ArticleId IdType="pubmed">175292</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1984 Mar;49(3):635-40</Citation><ArticleIdList><ArticleId IdType="pubmed">6321753</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1985 Jul 1;162(1):75-92</Citation><ArticleIdList><ArticleId IdType="pubmed">2409211</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1986 Feb;57(2):438-45</Citation><ArticleIdList><ArticleId IdType="pubmed">3003376</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1987 Jan;156(1):50-63</Citation><ArticleIdList><ArticleId IdType="pubmed">3027968</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1988 May;62(5):1647-52</Citation><ArticleIdList><ArticleId IdType="pubmed">2451756</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1990 Apr;64(4):1573-83</Citation><ArticleIdList><ArticleId IdType="pubmed">2157045</ArticleId></ArticleIdList></Reference><Reference><Citation>Virus Res. 1992 Jul;24(2):187-96</Citation><ArticleIdList><ArticleId IdType="pubmed">1326828</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1992 Nov 1;149(9):2906-13</Citation><ArticleIdList><ArticleId IdType="pubmed">1383332</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1993 Nov;197(1):501-5</Citation><ArticleIdList><ArticleId IdType="pubmed">8212594</ArticleId></ArticleIdList></Reference><Reference><Citation>J Lab Clin Med. 1994 Apr;123(4):485-91</Citation><ArticleIdList><ArticleId IdType="pubmed">7511675</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6245-8</Citation><ArticleIdList><ArticleId IdType="pubmed">7517044</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1994 Sep;68(9):5882-9</Citation><ArticleIdList><ArticleId IdType="pubmed">7914550</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 1994 Nov 1;13(21):5070-4</Citation><ArticleIdList><ArticleId IdType="pubmed">7525274</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1995 Mar;69(3):1903-6</Citation><ArticleIdList><ArticleId IdType="pubmed">7531780</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1995 Jun;69(6):3873-7</Citation><ArticleIdList><ArticleId IdType="pubmed">7538177</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1995 Sep;69(9):5497-501</Citation><ArticleIdList><ArticleId IdType="pubmed">7543583</ArticleId></ArticleIdList></Reference><Reference><Citation>Structure. 1995 Jul 15;3(7):653-67</Citation><ArticleIdList><ArticleId IdType="pubmed">8591043</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1995 Nov;69(11):6751-7</Citation><ArticleIdList><ArticleId IdType="pubmed">7474086</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1996 Nov;70(11):7811-8</Citation><ArticleIdList><ArticleId IdType="pubmed">8892902</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1996 Dec;70(12):9018-23</Citation><ArticleIdList><ArticleId IdType="pubmed">8971035</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1997 Jan;71(1):785-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8985417</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1997 Feb 28;275(5304):1320-3</Citation><ArticleIdList><ArticleId IdType="pubmed">9036860</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1997 Mar;175(3):697-700</Citation><ArticleIdList><ArticleId IdType="pubmed">9041347</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3352-6</Citation><ArticleIdList><ArticleId IdType="pubmed">9096397</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 1975 Sep;2(3):183-5</Citation><ArticleIdList><ArticleId IdType="pubmed">1176625</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>